Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Ovarian Cancer Action recently announced the award of a £600,000 grant to a team of Oxford Researchers led by Professor Ahmed Ashour Ahmed at the Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital.

The grant was awarded as part of a new open call competitive grant round, which we launched in June 2013 to attract innovative, novel and creative proposals for ovarian cancer research.

Professor Ahmed’s proposal is centred on the use of innovative approaches to monitor tumour response to chemotherapy using keyhole surgery.

The combination of direct monitoring of tumours and focused analysis of tumour samples will enable the identification of new treatment that would target the fundamental processes responsible for chemotherapy resistance to eradicate cancer cells.

The study will run for three years and involves extensive molecular, genetic and drug screens to identify novel therapies that are suited for individual patients.

The project was described by MSRC member Professor Ian Hart as one of the best proposals he had ever read.

Another peer reviewer said: ‘I doubt that there are very few, if any, other gynaecologists in the world capable of designing and completing this research, which may very well lead to improved personal treatment of ovarian cancer.


Similar stories

Ahmed group closer to finding the cell of origin for ovarian cancer

New research brings the Ahmed group closer to finding the cell of origin of ovarian cancer, and their ultimate aim of developing a much-needed screening tool for ovarian cancer.

New grant to tackle the immune response to ovarian cancer

Many congratulations to Prof Ahmed Ahmed and Prof Enzo Cerundolo, winners of the Ovarian Cancer Action International Grand Challenge Award.

Understanding the origins of ovarian cancer

Research into the early detection of ovarian cancer by the Ahmed group at the MRC WIMM receives a boost thanks to a gift of £43,000 from the Dianne Oxberry Trust.

MRC WIMM researchers win prestigious national awards

Congratulations to Prof Graham Ogg and Prof Paresh Vyas who have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their “outstanding contribution to clinical and applied health and social care research”. This is a tremendous achievement as these are highly competitive and prestigious awards.

Defining the role of lipids in skin inflammation

Congratulations to Prof Graham Ogg who has been awarded a Wellcome Trust Collaborative Award to investigate aspects of the immune response in skin diseases such as eczema, with the hope of identifying new treatment options.

New international collaborative network to study β-thalassaemia

A new grant from the UK Academy of Medical Sciences will allow clinicians and scientists from Oxford, Sri Lanka and Thailand to establish new ties to support research into β thalassaemia and benefit those most affected.